Abstract:
A method is provided for inhibiting the attachment of H. influenzae to human cells, such as pharyngeal cells, by contacting the bacilli with phosphorylated recombinant human β-casein that have at least 3 phosphate groups. A product containing phosphorylated recombinant human β-casein may be a liquid enteral nutritional product such as infant formula. The enteral nutritional product may be used for the prevention and treatment of otitis media in infants. The phosphorylated recombinant human β-casein may also be administered as a throat spray or used in nose drops or a spray.
Abstract:
Se provee un método para inhibir la union de H, influenzae a células humanas, tales como células faringeas, poniendo en contacto los bacilos con beta-caseina humana, recombinante, fosforilada, que tiene por lo menos 3 grupos fosfato. Un producto que contiene la beta-caseina humana, recombinante, fosforilada puede ser un producto nutricional enteral líquido, tal como una formula infantil. EL producto nutricional enteral puede ser utilizado para la prevencion y el tratamiento de otitis media en bebés. La beta-caseina humana, recombinante, fosforilada también puede ser administrada como una aspersion para la garganta o usarse en gotas para la nariz o una aspersion.
Abstract:
A method is provided for inhibiting the attachment of H. influenzae to human cells, such as pharyngeal cells, by contacting the bacilli with phosphorylated recombinant human .beta.-casein that have at least 3 phosphate groups. A product containing phosphorylated recombinant human .beta.-casein may be a liquid enteral nutritional product such as infant formula. The enteral nutritional product may be used for the prevention and treatment of otitis media in infants. The phosphorylated recombinant human .beta.-casein may also be administered as a throat spray or used in nose drops or a spray.
Abstract:
A method is provided for inhibiting the attachment of Haemophilus influenzae to human pharyngeal cells by contacting the bacilli with phosphorylated recombinant human b-casein that have at least 3 phosphate groups. A product containing phosphorylated recombinant human b-casein may be a liquid enteral nutritional product such as infant formula. The enteral nutritional product may be used for the prevention and treatment of otis media in infants. The phosphorylated recombinant human b-casein may also be administrated as a throat spray or used in nose drops or spray.